Literature DB >> 27365094

Consensus of recommendations guiding comparative effectiveness research methods.

Jacob B Morton1,2, Robert McConeghy1, Kirstin Heinrich3, Nicolle M Gatto4,5, Aisling R Caffrey1,2,6.   

Abstract

PURPOSE: Because of an increasing demand for quality comparative effectiveness research (CER), methods guidance documents have been published, such as those from the Agency for Healthcare Research and Quality (AHRQ) and the Patient-Centered Outcomes Research Institute (PCORI). Our objective was to identify CER methods guidance documents and compare them to produce a summary of important recommendations which could serve as a consensus of CER method recommendations.
METHODS: We conducted a systematic literature review to identify CER methods guidance documents published through 2014. Identified documents were analyzed for methods guidance recommendations. Individual recommendations were categorized to determine the degree of overlap.
RESULTS: We identified nine methods guidance documents, which contained a total of 312 recommendations, 97% of which were present in two or more documents. All nine documents recommended transparency and adaptation for relevant stakeholders in the interpretation and dissemination of results. Other frequently shared CER methods recommendations included: study design and operational definitions should be developed a priori and allow for replication (n = 8 documents); focus on areas with gaps in current clinical knowledge that are relevant to decision-makers (n = 7); validity of measures, instruments, and data should be assessed and discussed (n = 7); outcomes, including benefits and harms, should be clinically meaningful, and objectively measured (n = 7). Assessment for and strategies to minimize bias (n = 6 documents), confounding (n = 6), and heterogeneity (n = 4) were also commonly shared recommendations between documents.
CONCLUSIONS: We offer a field-consensus guide based on nine CER methods guidance documents that will aid researchers in designing CER studies and applying CER methods.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  comparative effectiveness research; consensus document; methods guides; pharmacoepidemiology

Mesh:

Year:  2016        PMID: 27365094     DOI: 10.1002/pds.4051

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  1 in total

1.  Considerations in characterizing real-world data relevance and quality for regulatory purposes: A commentary.

Authors:  Cynthia J Girman; Mary E Ritchey; Wei Zhou; Nancy A Dreyer
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-12-05       Impact factor: 2.890

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.